Premium
Experience with Implantable Cardioverter‐Defibrillator Therapy in Grown‐Ups with Congenital Heart Disease
Author(s) -
TOMASKE MAREN,
BAUERSFELD URS
Publication year - 2008
Publication title -
pacing and clinical electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 101
eISSN - 1540-8159
pISSN - 0147-8389
DOI - 10.1111/j.1540-8159.2008.00953.x
Subject(s) - medicine , psychosocial , implantable cardioverter defibrillator , sudden cardiac death , disease , intensive care medicine , heart disease , primary prevention , secondary prevention , implant , pediatrics , cardiology , surgery , psychiatry
Implantable cardioverter‐defibrillators (ICD) are increasingly implanted for primary or secondary prevention of sudden death in young patients with congenital heart disease, cardiomyopathies, or channelopathies. Although major advances in ICD technology and implant techniques have facilitated ICD therapy in young patients, complications such as lead failures, inappropriate shocks, system infections, and negative psychosocial impacts are of concern. The various underlying cardiovascular disease states and a lack of standardized ICD protocols for young patients often necessitate individualized implant techniques, ICD programming, and follow‐up. Young ICD patients need a thorough follow‐up to ensure adequate therapy, and psychosocial problems have to be addressed .